131 related articles for article (PubMed ID: 20953261)
1. Correspondence (letter to the editor): Need for advice.
Grass G; Mäder K
Dtsch Arztebl Int; 2010 Sep; 107(38):672; author reply 673-4. PubMed ID: 20953261
[No Abstract] [Full Text] [Related]
2. Correspondence (letter to the editor): Trend gives cause for concern.
Maier C; Zenz M
Dtsch Arztebl Int; 2010 Sep; 107(38):670-1; author reply 673-4. PubMed ID: 20953257
[No Abstract] [Full Text] [Related]
3. Correspondence (letter to the editor): Wholesale accusations?
Throm S
Dtsch Arztebl Int; 2010 Sep; 107(38):669; author reply 673-4. PubMed ID: 20953255
[No Abstract] [Full Text] [Related]
4. Correspondence (letter to the editor): Opinion leaders.
Sachtleben S
Dtsch Arztebl Int; 2010 Sep; 107(38):669-70; author reply 673-4. PubMed ID: 20953256
[No Abstract] [Full Text] [Related]
5. Research dishonesty and conflict of interest.
Frizelle F
N Z Med J; 2002 Dec; 115(1167):U270. PubMed ID: 12552259
[No Abstract] [Full Text] [Related]
6. Research funding, conflicts of interest, and the meta-methodology of public relations.
Rampton S; Stauber J
Public Health Rep; 2002; 117(4):331-9. PubMed ID: 12477914
[No Abstract] [Full Text] [Related]
7. Correspondence (letter to the editor): Notorious weaknesses.
Maares J
Dtsch Arztebl Int; 2010 Sep; 107(38):670; author reply 673-4. PubMed ID: 20953258
[No Abstract] [Full Text] [Related]
8. Drug research: marketing before evidence, sales before safety.
Klemperer D
Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552
[No Abstract] [Full Text] [Related]
9. [For and against: does sponsoring impede the growth of knowledge in medicine?].
Finzen A; Fritze J
Psychiatr Prax; 2007 May; 34(4):162-4. PubMed ID: 17520527
[No Abstract] [Full Text] [Related]
10. The impact of selective publication on clinical research in pain.
Rowbotham MC
Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556
[No Abstract] [Full Text] [Related]
11. Correspondence (letter to the editor): Search bias.
Braschoss A
Dtsch Arztebl Int; 2010 Sep; 107(38):671-2; author reply 673-4. PubMed ID: 20953260
[No Abstract] [Full Text] [Related]
12. Is the influence of the pharmaceutical industry on prescribing, research and publication in the field of psychogeriatrics excessive? - No.
Bhattacharyya S; Burns A
Int Psychogeriatr; 2007 Dec; 19(6):1010-4; discussion 1014-20. PubMed ID: 17711609
[No Abstract] [Full Text] [Related]
13. Profits, pressure, and perception: expensive research collides with medicine.
Hoey J
J Rheumatol; 2003 Aug; 30(8):1661-2. PubMed ID: 12913915
[No Abstract] [Full Text] [Related]
14. Yes, industry influence is excessive.
Shah AA; Finucane TE
Int Psychogeriatr; 2007 Dec; 19(6):1004-10; discussion 1014-20. PubMed ID: 17711608
[No Abstract] [Full Text] [Related]
15. Bias in the design, interpretation, and publication of industry-sponsored clinical research.
Hammerschmidt D
Minn Med; 2008 Jun; 91(6):46-7. PubMed ID: 18616022
[No Abstract] [Full Text] [Related]
16. Correspondence (letter to the editor): National foundation.
Freund M
Dtsch Arztebl Int; 2010 Sep; 107(38):671; author reply 673-4. PubMed ID: 20953259
[No Abstract] [Full Text] [Related]
17. Research from tobacco industry affiliated authors: need for particular vigilance.
Chapman S
Tob Control; 2005 Aug; 14(4):217-9. PubMed ID: 16046673
[No Abstract] [Full Text] [Related]
18. Is drug research trustworthy? The pharmaceutical industry funnels money to prominent scientists who are doing research that affects its products--and nobody can stop it.
Seife C
Sci Am; 2012 Dec; 307(6):56-63. PubMed ID: 23230798
[No Abstract] [Full Text] [Related]
19. Fraud and deceit in medical research.
Ramnarain N; Kirk P
Br J Hosp Med (Lond); 2007 Oct; 68(10):543-6. PubMed ID: 17974302
[TBL] [Abstract][Full Text] [Related]
20. Publication ethics and the ghost management of medical publication.
Sismondo S; Doucet M
Bioethics; 2010 Jul; 24(6):273-83. PubMed ID: 19222451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
